COMPERA 2.0 risk stratification in medically managed chronic thromboembolic pulmonary hypertension

Stubbs, H. , Lua, S., Brewis, M., Johnson, M. and Church, C. (2022) COMPERA 2.0 risk stratification in medically managed chronic thromboembolic pulmonary hypertension. European Respiratory Journal, 60, 2200313. (doi: 10.1183/13993003.00313-2022) (PMID:35798358)

Full text not currently available from Enlighten.

Abstract

The newly proposed COMPERA 2.0 risk stratification model provides improved clinical refinement and is applicable in medically managed chronic thromboembolic pulmonary hypertension (CTEPH).

Item Type:Articles (Letter)
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Lua, Dr Stephanie and Brewis, Dr Melanie and Stubbs, Dr Harrison and Church, Dr Colin
Authors: Stubbs, H., Lua, S., Brewis, M., Johnson, M., and Church, C.
College/School:College of Medical Veterinary and Life Sciences > School of Cancer Sciences
College of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic Health
College of Medical Veterinary and Life Sciences > School of Medicine, Dentistry & Nursing
Journal Name:European Respiratory Journal
Publisher:European Respiratory Society
ISSN:0903-1936
ISSN (Online):1399-3003
Copyright Holders:Copyright: © The Authors 2022

University Staff: Request a correction | Enlighten Editors: Update this record